Published in J Am Soc Nephrol on June 01, 2003
The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol (2007) 3.51
Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest (2010) 3.41
The human "Treg MLR": immune monitoring for FOXP3+ T regulatory cell generation. Transplantation (2009) 1.06
Pathways of major histocompatibility complex allorecognition. Curr Opin Organ Transplant (2008) 1.02
Influence of direct and indirect allorecognition pathways on CD4+CD25+ regulatory T-cell function in transplantation. Transpl Int (2007) 0.92
Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation. Front Immunol (2012) 0.91
Microchimerism in promoting graft acceptance in clinical transplantation. Curr Opin Organ Transplant (2011) 0.81
Detailed kinetics of the direct allo-response in human liver transplant recipients: new insights from an optimized assay. PLoS One (2010) 0.76
Regulatory T cells in kidney transplant recipients: active players but to what extent? J Am Soc Nephrol (2003) 0.75
Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med (2012) 6.93
Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest (2002) 5.83
Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest (2010) 3.59
Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest (2010) 3.41
A CD8+ T cell transcription signature predicts prognosis in autoimmune disease. Nat Med (2010) 2.88
B-cell-depleting induction therapy and acute cellular rejection. N Engl J Med (2009) 2.56
Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. Blood (2006) 2.42
In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance. Blood (2006) 2.28
A novel pathway of alloantigen presentation by dendritic cells. J Immunol (2004) 1.94
Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J Clin Invest (2003) 1.87
Balancing susceptibility to infection and autoimmunity: a role for leptin? Trends Immunol (2002) 1.84
Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types. Cell Stem Cell (2012) 1.75
A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum (2009) 1.74
Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification. BMC Genomics (2007) 1.74
Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo. Blood (2003) 1.63
Organ transplantation: halfway through the first century. J Am Soc Nephrol (2004) 1.59
Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells. Sci Transl Med (2011) 1.56
Predicting HLA class I alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms. Transplantation (2009) 1.49
Leptin accelerates autoimmune diabetes in female NOD mice. Diabetes (2002) 1.43
Ten-year experience of selective omission of the pretransplant crossmatch test in deceased donor kidney transplantation. Transplantation (2010) 1.41
Pathways of allorecognition: implications for transplantation tolerance. Transpl Immunol (2002) 1.41
Inhibition of thrombin receptor signaling on α-smooth muscle actin(+) CD34(+) progenitors leads to repair after murine immune vascular injury. Arterioscler Thromb Vasc Biol (2011) 1.39
Human CD4+CD25+ regulatory cells have marked and sustained effects on CD8+ T cell activation. Eur J Immunol (2003) 1.35
Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. J Leukoc Biol (2002) 1.33
New spectrum of allorecognition pathways: implications for graft rejection and transplantation tolerance. Curr Opin Immunol (2004) 1.30
Cutting Edge: Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients. J Immunol (2011) 1.25
Chronic exposure to Helicobacter pylori impairs dendritic cell function and inhibits Th1 development. Infect Immun (2006) 1.21
Physiologic and aberrant regulation of memory T-cell trafficking by the costimulatory molecule CD28. Blood (2007) 1.20
Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis. Ann Rheum Dis (2009) 1.16
Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in Goodpasture's (anti-GBM) disease. Kidney Int (2003) 1.15
Helicobacter pylori stimulates dendritic cells to induce interleukin-17 expression from CD4+ T lymphocytes. Infect Immun (2009) 1.15
Regulatory T cells as therapeutic cells. Curr Opin Organ Transplant (2008) 1.14
Immunologic monitoring. Immunol Rev (2003) 1.13
Differential effects of rapamycin and retinoic acid on expansion, stability and suppressive qualities of human CD4(+)CD25(+)FOXP3(+) T regulatory cell subpopulations. Haematologica (2012) 1.12
Cognate recognition of the endothelium induces HY-specific CD8+ T-lymphocyte transendothelial migration (diapedesis) in vivo. Blood (2003) 1.12
A rapid diagnostic test for human regulatory T-cell function to enable regulatory T-cell therapy. Blood (2012) 1.10
Complement abnormalities in acquired lipodystrophy revisited. J Clin Endocrinol Metab (2008) 1.10
Regulatory T cells and transplantation tolerance. Hum Immunol (2006) 1.09
Complete inhibition of acute humoral rejection using regulated expression of membrane-tethered anticoagulants on xenograft endothelium. Am J Transplant (2004) 1.08
CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner. Eur J Immunol (2013) 1.07
Protease-activated receptor 1 activation is necessary for monocyte chemoattractant protein 1-dependent leukocyte recruitment in vivo. J Exp Med (2008) 1.07
Qualitatively distinct patterns of cytokines are released by human dendritic cells in response to different pathogens. Immunology (2005) 1.04
The T helper 17-regulatory T cell axis in transplant rejection and tolerance. Curr Opin Organ Transplant (2009) 1.04
The accuracy of diagnostic coding for acute kidney injury in England - a single centre study. BMC Nephrol (2013) 1.03
The importance of the indirect pathway of allorecognition in clinical transplantation. Curr Opin Immunol (2008) 1.03
Pathways of major histocompatibility complex allorecognition. Curr Opin Organ Transplant (2008) 1.02
Activated CD1d-restricted natural killer T cells secrete IL-2: innate help for CD4+CD25+ regulatory T cells? Eur J Immunol (2005) 1.01
Comparison of regulatory T cells in hemodialysis patients and healthy controls: implications for cell therapy in transplantation. Clin J Am Soc Nephrol (2013) 1.01
Long-term efficacy and safety of rituximab in refractory and relapsing systemic lupus erythematosus. Nephrol Dial Transplant (2010) 1.00
Achieving permanent survival of islet xenografts by independent manipulation of direct and indirect T-cell responses. Diabetes (2005) 1.00
T-cell alloimmunity and chronic allograft dysfunction. Kidney Int Suppl (2010) 0.99
Transplantation tolerance induced by regulatory T cells: in vivo mechanisms and sites of action. Int Immunopharmacol (2009) 0.98
ACE inhibitor and angiotensin receptor-II antagonist prescribing and hospital admissions with acute kidney injury: a longitudinal ecological study. PLoS One (2013) 0.97
A novel pathway of antigen presentation by dendritic and endothelial cells: Implications for allorecognition and infectious diseases. Transplantation (2006) 0.96
Monitoring of in vivo function of superparamagnetic iron oxide labelled murine dendritic cells during anti-tumour vaccination. PLoS One (2011) 0.94
A 'biomarker signature' for tolerance in transplantation. Nat Rev Nephrol (2010) 0.93
Generation and expansion of human CD4+ CD25+ regulatory T cells with indirect allospecificity: Potential reagents to promote donor-specific transplantation tolerance. Transplantation (2006) 0.93
Dendritic cells from CML patients have altered actin organization, reduced antigen processing, and impaired migration. Blood (2002) 0.93
Cross-species costimulation: relative contributions of CD80, CD86, and CD40. Transplantation (2003) 0.91
Acquisition of HLA-DR and costimulatory molecules by T cells from allogeneic antigen presenting cells. Am J Transplant (2005) 0.91
Towards the identification of biomarkers of transplantation tolerance. Nat Rev Immunol (2009) 0.91
Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation. Front Immunol (2012) 0.91
Regulatory T cells in the control of transplantation tolerance and autoimmunity. Am J Transplant (2003) 0.91
Acquisition of MHC:peptide complexes by dendritic cells contributes to the generation of antiviral CD8+ T cell immunity in vivo. J Immunol (2012) 0.91
Predicting HLA class II alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms. Transplantation (2011) 0.90
Analysis of the peripheral T-cell repertoire in kidney transplant patients. Eur J Immunol (2010) 0.89
Creation of tolerogenic human dendritic cells via intracellular CTLA4: a novel strategy with potential in clinical immunosuppression. Blood (2005) 0.89
In vivo SPECT reporter gene imaging of regulatory T cells. PLoS One (2011) 0.89
Induction of tumor-specific T-cell responses by vaccination with tumor lysate-loaded dendritic cells in colorectal cancer patients with carcinoembryonic-antigen positive tumors. Cancer Immunol Immunother (2007) 0.88
Origin and biology of the allogeneic response. Cold Spring Harb Perspect Med (2013) 0.87
IL-13 production by donor T cells is prognostic of acute graft-versus-host disease following unrelated donor stem cell transplantation. Blood (2003) 0.87
Expansion of hepatitis C-specific CD4+CD25+ regulatory T cells after viral clearance: a mechanism to limit collateral damage? J Allergy Clin Immunol (2008) 0.86
Regulation of rat and human T-cell immune response by pharmacologically modified dendritic cells. Transplantation (2009) 0.86
The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease. BMC Musculoskelet Disord (2014) 0.86
From current immunosuppressive strategies to clinical tolerance of allografts. Transpl Int (2007) 0.85
In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity. Int Immunopharmacol (2006) 0.85
Everolimus and basiliximab permit suppression by human CD4+CD25+ cells in vitro. Am J Transplant (2005) 0.85
High-resolution, three-dimensional modeling of human leukocyte antigen class I structure and surface electrostatic potential reveals the molecular basis for alloantibody binding epitopes. Hum Immunol (2011) 0.85
Detection of immunoglobulin G human leukocyte antigen-specific alloantibodies in renal transplant patients using single-antigen-beads is compromised by the presence of immunoglobulin M human leukocyte antigen-specific alloantibodies. Transplantation (2009) 0.84
Arvanil inhibits T lymphocyte activation and ameliorates autoimmune encephalomyelitis. J Neuroimmunol (2005) 0.83
Endothelial cell cytoprotection induced in vitro by allo- or xenoreactive antibodies is mediated by signaling through adenosine A2 receptors. Eur J Immunol (2003) 0.83
Anergic T cells exert antigen-independent inhibition of cell-cell interactions via chemokine metabolism. Blood (2003) 0.83
Transitional-2 B cells acquire regulatory function during tolerance induction and contribute to allograft survival. Eur J Immunol (2014) 0.83
A comprehensive study of clinical, biochemical, radiological, vascular, cardiac, and sleep parameters in an unselected cohort of patients with acromegaly undergoing presurgical somatostatin receptor ligand therapy. J Clin Endocrinol Metab (2013) 0.83
Chronic graft loss. Immunological and non-immunological factors. Contrib Nephrol (2005) 0.82
Tolerant T cells display impaired trafficking ability. Eur J Immunol (2005) 0.81
Comparison of phenotype and outcome in microscopic polyangiitis between Europe and Japan. J Rheumatol (2014) 0.80
CD4+CD25+ regulatory T cell therapy for the induction of donor-specific clinical transplantation tolerance. Expert Opin Biol Ther (2006) 0.80
Regenerative repair after endoluminal injury in mice with specific antagonism of protease activated receptors on CD34+ vascular progenitors. Blood (2008) 0.80
CD4+CD25+ regulatory T-cell therapy for allergy, autoimmune disease and transplant rejection. Inflamm Allergy Drug Targets (2006) 0.80
Functional consequences of noncognate interactions between CD4+ memory T lymphocytes and the endothelium. J Immunol (2002) 0.79
Anti-TNFalpha therapy--killing two birds with one stone? Lancet (2010) 0.79
Retrospective tissue typing of the kidney donor from recipient urine. Kidney Int (2008) 0.79